REHABCARE GROUP INC
10-Q, 2000-05-15
HOSPITALS
Previous: BIO MEDICAL AUTOMATION INC, NT 10-Q, 2000-05-15
Next: ATA RESEARCH PROFUTURES DIVERSIFIED FUND L P, 10-Q, 2000-05-15









<PAGE> 1




                        SECURITIES AND EXCHANGE COMMISSION

                              WASHINGTON, D.C. 20549


                                     FORM 10-Q


              QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
                          SECURITIES EXCHANGE ACT OF 1934

                   For the quarterly period ended March 31, 2000

                          Commission File Number 0-19294


                               REHABCARE GROUP, INC.
              (Exact name of Registrant as specified in its charter)

          Delaware                                    51-0265872
(State or other jurisdiction of        (I.R.S. Employer Identification Number)
incorporation or organization)


              7733 Forsyth Boulevard, Suite 1700, St. Louis, MO 63105
               (Address of principal executive offices and zip code)

                                    314-863-7422
               (Registrant's telephone number, including area code)


Indicate by check mark whether the Registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the  preceding 12 months (or for such  shorter  period that the  Registrant  was
required  to file  such  reports),  and  (2) has  been  subject  to such  filing
requirements for the past 90 days.

                        Yes    X                 No


Indicate the number of shares  outstanding of the Registrant's  common stock, as
of the latest practicable date.


                Class                             Outstanding at May 10, 2000
- --------------------------------------            ---------------------------
Common Stock, par value $.01 per share                    7,269,480

- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------

                                    1 of 12



<PAGE> 2


                                   REHABCARE GROUP, INC.

                                       Index



Part I. - Financial Information

   Item 1. - Condensed Consolidated Financial Statements

      Condensed consolidated balance sheets,
        March 31, 2000 (unaudited) and December 31, 1999                   3

      Condensed consolidated statements of earnings for the three
        months ended March 31, 2000 and 1999 (unaudited)                   4

      Condensed consolidated statements of cash flows for the
        three months ended March 31, 2000 and 1999 (unaudited)             5

      Notes to condensed consolidated financial statements (unaudited)     6

   Item 2. - Management's Discussion and Analysis of Financial
      Condition and Results of Operations                                  9

Part II. - Other Information

   Item 4. - Submission of Matters to Security Holders                    11

   Item 6. - Exhibits and Reports on Form 8-K                             11

   Signatures                                                             12
















                                    2 of 12



<PAGE> 3


PART 1. - FINANCIAL INFORMATION
Item 1. - Condensed Consolidated Financial Statements
<TABLE>

                                   REHABCARE GROUP, INC.

                           Condensed Consolidated Balance Sheets
                       (dollars in thousands, except per share data)

<CAPTION>

                                                        March 31,  December 31,
                                                         2000         1999
                                                         ----         ----
                                                       (unaudited)
<S>                                                   <C>           <C>
Assets:
Current assets:
    Cash and cash equivalents                         $    963          738
    Marketable securities, available-for-sale            3,019        3,019
    Accounts receivable, net of allowance for doubtful
      accounts of $4,761 and $4,577, respectively       78,856       65,777
    Deferred tax assets                                  5,460        4,898
    Prepaid expenses and other current assets              899        1,100
                                                       -------      -------
      Total current assets                              89,197       75,532
Marketable securities, trading                           2,133        1,777
Equipment and leasehold improvements, net                8,211        7,269
Excess of cost over net assets acquired, net            98,359       99,020
Other                                                    4,394        3,666
                                                       -------      -------
                                                      $202,294      187,264
                                                       =======      =======
Liabilities and Stockholders' Equity:
Current liabilities:
    Current portion of long-term debt                 $ 13,319       13,345
    Accounts payable                                     4,379        3,359
    Accrued salaries and wages                          17,658       16,884
    Accrued expenses                                    10,358       11,592
    Income taxes payable                                 4,135        3,283
                                                       -------      -------
      Total current liabilities                         49,849       48,463
Deferred compensation and other long-term
   liabilities                                           2,560        3,623
Deferred tax liabilities                                 1,946        1,345
Long-term debt, less current portion                    58,067       56,050
                                                       -------      -------
      Total liabilities                                112,422      109,481
                                                       =======      =======

Stockholders' equity:
    Preferred stock, $.10 per value,
      10,000,000 shares, none issued and outstanding        --           --
    Common stock, $.01 par value; authorized 20,000,000
      shares, issued 8,325,212 and 7,850,283 shares,
      respectively                                          83           79
    Additional paid-in capital                          39,653       33,179
    Retained earnings                                   68,099       62,488
    Less common stock held in treasury at cost,
      1,165,597 shares                                 (17,975)     (17,975)
    Accumulated other comprehensive earnings                12           12
                                                       -------      -------
      Total stockholders' equity                        89,872       77,783
                                                       -------      -------
                                                      $202,294      187,264
                                                       =======      =======

</TABLE>

             See notes to condensed consolidated financial statements.

                                    3 of 12

<PAGE> 4


<TABLE>
                               REHABCARE GROUP, INC.

                    Condensed Consolidated Statements of Earnings
                    (dollars in thousands, except per share data)
                                     (Unaudited)

<CAPTION>

                                                                  Three Months Ended
                                                                       March 31,
                                                                      2000      1999
                                                                      ----      ----
<S>                                                              <C>          <C>

Operating revenues                                               $ 105,933    69,185
Costs and expenses:
   Operating expenses                                               75,244    49,478
   General and administrative                                       18,586    11,811
   Depreciation and amortization                                     1,516     1,208
                                                                    ------    ------
     Total costs and expenses                                       95,346    62,497
                                                                    ------    ------
     Operating earnings                                             10,587     6,688
Interest income                                                         49        65
Interest expense                                                    (1,324)   (1,065)
Other income (expense), net                                              8        (2)
                                                                    ------    ------
Earnings before income taxes                                         9,320     5,686
Income taxes                                                         3,709     2,256
                                                                    ------    ------
     Net earnings                                                $   5,611     3,430
                                                                    ======    ======

Net earnings per common share:
     Basic                                                       $     .81       .53
                                                                    ======    ======
     Diluted                                                     $     .73       .47
                                                                    ======    ======
Weighted average number of common shares outstanding:
     Basic                                                           6,925     6,508
                                                                    ======    ======
     Diluted                                                         7,683     7,358
                                                                    ======    ======

</TABLE>

                 See notes to condensed consolidated financial statements.

                                    4 of 12

<PAGE> 5


<TABLE>
                                REHABCARE GROUP, INC.

                   Condensed Consolidated Statements of Cash Flows
                               (dollars in thousands)
                                     (Unaudited)
<CAPTION>


                                                            Three Months Ended
                                                                 March 31,
                                                             2000       1999
                                                             ----       ----
<S>                                                        <C>         <C>
Cash flows from operating activities:
   Net earnings                                            $5,611      3,430
   Adjustments to reconcile net earnings to net
     cash provided by operating activities:
        Depreciation and amortization                       1,516      1,208
        Provision for losses on accounts receivable           992        351
        Increase (decrease) in deferred compensation          (48)       416
        Increase in accounts receivable, net              (14,071)      (654)
        Decrease (increase) in prepaid expenses and
           other current assets                               201       (505)
        Increase in other assets                             (320)       (52)
        Increase (decrease) in accounts payable
           and accrued expenses                            (1,229)       577
        Increase (decrease) in accrued salaries and wages     774       (511)
        Increase in income taxes payable and deferred         891        598
                                                            -----      -----
               Net cash provided by (used in)
                  operating activities                     (5,683)     4,858
                                                            -----      -----

Cash flows from investing activities:
   Additions to equipment and leasehold improvements, net  (1,516)      (453)
   Purchase of marketable securities                         (489)      (350)
   Deferred contract costs                                   (334)      (200)
   Proceeds from sale/maturities of investments               133         --
   Other                                                     (355)       (28)
                                                            -----      -----
               Net cash used in investing activities       (2,561)    (1,031)
                                                            -----      -----

Cash flows from financing activities:
   Proceeds from revolving credit facility, net            10,900         --
   Payments on long-term debt                              (2,909)    (2,962)
   Exercise of stock options, including tax benefit           478        307
                                                            -----      -----
               Net cash provided by (used in)
                  financing activities                      8,469     (2,655)
                                                            -----      -----

               Net increase in cash and cash equivalents      225      1,172

Cash and cash equivalents at beginning of period              738      5,666
                                                            -----      -----

Cash and cash equivalents at end of period                 $  963      6,838
                                                            =====      =====
</TABLE>


              See notes to condensed consolidated financial statements.

                                    5 of 12


<PAGE> 6


                                   REHABCARE GROUP, INC.

                    NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                                        (Unaudited)


Note 1. - Basis of Presentation

The condensed  consolidated  balance sheets and related  condensed  consolidated
statements  of earnings and cash flows  contained  in this Form 10-Q,  which are
unaudited,   include  the   accounts  of  the  Company  and  its  wholly   owned
subsidiaries.  All  significant  intercompany  accounts and  activity  have been
eliminated  in  consolidation.  In the opinion of  management,  all  adjustments
necessary  for a fair  presentation  of  such  financial  statements  have  been
included.  Adjustments  consisted only of normal recurring items. The results of
operations  for the three  months  ended  March 31,  2000,  are not  necessarily
indicative  of the results to be expected  for the fiscal  year.  Certain  prior
years'  amounts  have  been  reclassified  to  conform  with  the  current  year
presentation.

The condensed  consolidated  financial statements do not include all information
and  footnotes  necessary  for a complete  presentation  of financial  position,
results of  operations  and cash flows in  conformity  with  generally  accepted
accounting  principles.  Reference is made to the Company's audited consolidated
financial  statements and the related notes as of December 31, 1999 and 1998 and
for each of the years in the three year period ended December 31, 1999, included
in the  Annual  Report  on Form 10-K on file with the  Securities  and  Exchange
Commission,  which provide additional  disclosures and a further  description of
accounting policies.


Note 2. - Conversion of Note Payable

On February 14, 2000, the $6.0 million convertible subordinated notes payable to
the former Healthcare  Staffing Solutions,  Inc.  shareholders were converted to
Company Common Stock.  The conversion  price was $14.17 per share,  resulting in
the issuance of 423,526 shares of Company Common Stock.  This transaction had no
effect on diluted earnings per share.

                                    6 of 12


<PAGE> 7


<TABLE>
Note 3. - Earnings per Share

The following table sets forth the computation of basic and diluted earnings per
share:
(dollars in thousands, except per share data)
<CAPTION>

                                                                   Three Months Ended
                                                                        March 31,
                                                                    2000        1999
                                                                    ----        ----
<S>                                                               <C>          <C>
Numerator:

Numerator for basic earnings per share - earnings available
   to common stockholders (net earnings)                          $5,611       3,430

Effect of dilutive securities - after-tax interest on
   convertible subordinated promissory notes                          28          55
                                                                   -----       -----

Numerator for diluted earnings per share - earnings available
   to common stockholders after assumed conversions               $5,639       3,485
                                                                   =====       =====

Denominator:

Denominator for basic earnings per share - weighted-average
   shares outstanding                                              6,925       6,508

Effect of dilutive securities:
   Stock options                                                     549         427

   Convertible subordinated promissory notes                         209         423
                                                                   -----       -----

Denominator for diluted earnings per share - adjusted
   weighted-average shares and assumed conversions                 7,683       7,358
                                                                   =====       =====

Basic earnings per share                                          $  .81         .53
                                                                   =====       =====

Diluted earnings per share                                        $  .73         .47
                                                                  =====        =====
</TABLE>

                                    7 of 12


<PAGE> 8


Note 4. - Industry Segment Information

The Company operates in four business segments that are managed separately based
on fundamental  differences in operations:  inpatient programs  (including acute
rehabilitation and skilled nursing units), outpatient programs, contract therapy
services and staffing.  All of the Company's services are provided in the United
States.  Summarized  information  about the Company's  operations  for the three
months  ended  March 31, 2000 and 1999 in each  industry  segment is as follows:
(dollars in thousands)
<TABLE>
<CAPTION>
                                                                  Three Months Ended
                                                                        March 31,
                                                                    2000        1999
                                                                    ----        ----
<S>                                                             <C>          <C>
Revenues from Unaffiliated Customers
Inpatient                                                       $ 30,511      28,987
Outpatient                                                         9,660       6,356
Contract Therapy                                                   6,200       2,778
Staffing                                                          59,562      31,064
                                                                 -------     -------
Total                                                           $105,933      69,185
                                                                 =======     =======


Operating Earnings
Inpatient                                                       $  5,278       4,969
Outpatient                                                         1,954       1,126
Contract Therapy                                                     676        (197)
Staffing                                                           2,679         790
                                                                 -------     -------
Total                                                           $ 10,587       6,688
                                                                 =======     =======


Total Assets
Inpatient                                                       $ 55,826      56,668
Outpatient                                                        20,066      12,156
Contract Therapy                                                  21,407      18,583
Staffing                                                         104,995      71,276
                                                                 -------     -------
Total                                                           $202,294     158,683
                                                                 =======     =======


Depreciation and Amortization
Inpatient                                                       $    631         599
Outpatient                                                           165          93
Contract Therapy                                                      96          87
Staffing                                                             624         429
                                                                 -------     -------
Total                                                           $  1,516       1,208
                                                                 =======     =======


Capital Expenditures
Inpatient                                                       $    912         343
Outpatient                                                            39          21
Contract Therapy                                                       9           1
Staffing                                                             556          88
                                                                 -------     -------
Total                                                           $  1,516         453
                                                                 =======     =======

</TABLE>

                             8 of 12

<PAGE> 9


Note 5. - Current Developments in Accounting and Reporting

In December 1999, the Securities and Exchange  Commission ("SEC") released Staff
Accounting Bulletin No. 101, "Revenue Recognition in Financial Statements." This
bulletin  summarizes  certain  views  of the SEC  staff  on  applying  generally
accepted accounting  principles to revenue recognition in financial  statements.
Management  is  currently  in the  process  of  evaluating  the  impact  of this
bulletin,  but does not expect a material effect on the  consolidated  financial
statements.  This bulletin is effective  beginning the second  quarter of fiscal
2000.


Item 2. -  Management's  Discussion  and  Analysis of  Financial  Condition  and
Results of Operations

Results of Operations

The Company provides physical medicine, rehabilitation and chronic care services
in a variety of settings under  multi-year  contracts.  These  settings  include
distinct-part acute  rehabilitation  programs that may or may not be exempt from
the Medicare  Prospective  Payment System  ("PPS"),  depending on their stage of
development; subacute programs that are operated within licensed skilled nursing
units;  outpatient  clinics,  both on and off campus of the host  hospital,  and
therapy services for long-term care facilities and school districts. The Company
also is a contract  provider of nurse and other medical staffing on a continuing
and temporary basis to hospitals and long-term care facilities.
<TABLE>
<CAPTION>

                                                         Three Months Ended
Operating Statistics                                          March 31,
                                                           2000       1999
                                                           ----       ----
<S>                                                     <C>        <C>
Program Management:
    Inpatient Programs (Acute and Subacute)
    Average bed capacity                                  2,634      2,590
    Average billable length of stay (days)                 14.3       14.3
    Billable patient days served                        181,856    174,583
    Admissions                                           12,681     12,217
    Average daily billable census                         1,998      1,940
    Average occupied beds per program                      14.8       14.8
    Total programs in operation at end of period            132        131

    Outpatient Clinics
    Patient visits                                      259,409    158,603
    Units of service                                    717,812    427,339
    Total clinics in operation at end of period              46         34

    Contract Therapy
    Number of locations at end of period                    141         77

    Staffing
    Weeks worked                                         52,864     27,430
</TABLE>


Three Months Ended March 31, 2000 Compared to Three Months Ended March 31, 1999

Operating revenues during the first quarter 2000 increased by $36.7 million,  or
53.1%, to $105.9 million as compared to the first quarter of 1999.  Acquisitions
accounted for 23.6% of the net increase.  Inpatient program revenue increased by

                                    9 of 12
<PAGE> 10

$1.5  million  to $30.5  million.  A 2.7%  increase  in the  average  number  of
inpatient  programs from 131.3 to 134.8 programs,  combined with a 0.3% increase
in the average daily billable census per inpatient program to 14.8 resulted in a
4.2%  increase in billable  patient  days to 181,856.  The  increase in billable
patient days,  combined with a 1.0% increase in average per diem billing  rates,
generated a 5.3% increase in revenue from  inpatient  programs.  The increase in
billable census per program for inpatient programs is primarily  attributable to
a 1.1% increase in admissions per program. Outpatient revenue increased 52.0% to
$9.7 million,  reflecting $1.3 million from the May 20, 1999 acquisition of Salt
Lake Physical  Therapy  Associates  Inc.,  an increase in the average  number of
outpatient  clinics  managed  from  35.7 to 45.9,  and an  increase  in units of
service per clinic.  Contract therapy revenue  increased 123.2% to $6.2 million,
reflecting  an  increase in the average  number of  contract  therapy  locations
managed from 75.5 to 134.8, and an increase in revenue per location.

Staffing revenue increased 91.7% to $59.6 million,  reflecting $1.5 million from
the July 1, 1999  acquisition of AllStaff,  Inc., $5.9 million from the December
20, 1999 acquisition of eai Healthcare Staffing Solutions, Inc. ("eai Healthcare
Staffing"),  and a 58.4%  increase  in  weeks  worked  at  existing  travel  and
supplemental offices from 27,420 to 43,459.

Operating  expenses for the three months ended March 31, 2000 increased by $25.8
million,  or 52.1%, to $75.2 million as compared to the three months ended March
31, 1999.  Acquisitions  accounted for approximately  22.3% of the net increase.
The remaining  increase in operating expenses is attributable to the increase in
patient days,  units of services,  increased  contract  therapy  locations,  and
increased weeks worked from travel and supplemental staffing offices.

General and administrative  expenses increased $6.8 million,  or 57.4%, to $18.6
million, reflecting increases in corporate office expenses as well as marketing,
business  development,  operations and  professional  services in support of the
increase in inpatient programs,  outpatient clinics,  contract therapy locations
and staffing offices,  plus the addition of general and administrative  expenses
of companies acquired.

Depreciation  and  amortization  increased  $308,000  reflecting  an increase in
goodwill from acquisitions.

Interest  expense  increased  $259,000  reflecting  interest on additional  debt
funding  the  acquisitions,  borrowings  under the  revolving  loan for  working
capital purposes and an increase in interest rates.

Earnings  before  income taxes  increased  by $3.6  million,  or 63.9%,  to $9.3
million.  The provision  for income taxes for 2000 was $3.7 million  compared to
$2.3 million in 1999,  reflecting effective income tax rates of 39.8% and 39.7%,
respectively. Net earnings increased by $2.2 million, or 63.6%, to $5.6 million.
Diluted  earnings per share increased 55.3% to $.73 from $.47 on a 4.4% increase
in the weighted-average shares and assumed conversions outstanding. The increase
in  diluted  shares  outstanding  is  attributable  primarily  to  stock  option
exercises  and shares  issued in  acquisitions,  and an increase in the dilutive
effect of stock options  resulting  from an increase in the average market price
of the Company's stock relative to the underlying exercise prices of outstanding
options.


Liquidity and Capital Resources

As of March  31,  2000,  the  Company  had  $4.0  million  in cash  and  current
marketable securities and a current ratio of 1.8:1. Working capital increased by

                                    10 of 12
<PAGE> 11

$12.3  million as of March 31, 2000,  compared to December  31, 1999,  primarily
reflecting  working capital from the acquisition of eai Healthcare  Staffing and
working capital generated from operations.

Net accounts  receivable were $78.9 million at March 31, 2000, compared to $65.8
million at December  31,  1999.  The number of day's  average net revenue in net
receivables was 67.7 at March 31, 2000 compared to 65.6 at December 31, 1999.

The Company's  operating  cash flows  constitute its primary source of liquidity
and  historically  have been  sufficient  to fund its working  capital,  capital
expenditure,  business  expansion  and debt  service  requirements.  The Company
expects  to meet its  future  working  capital,  capital  expenditure,  business
expansion and debt service  requirements  from a combination of internal sources
and outside financing.  The Company has a $30.0 million revolving line of credit
with a balance  outstanding as of March 31, 2000 of $22.9  million.  The Company
made additional borrowings in the first quarter of 2000 under its revolving line
of credit to fund its $2.0  million  letter of credit and to  finance  its rapid
growth in revenues  and  accounts  receivable.  The Company  believes it has the
ability to expand its borrowing capacity, if necessary,  to meet working capital
and acquisition requirements.


Part II. - OTHER INFORMATION

Item 4. - Submission of Matters to Security Holders

The Annual Meeting of Stockholders of the Company was held on Wednesday, May 10,
2000, at which time the stockholders voted to elect the six incumbent  directors
to hold office until the next annual meeting of  stockholders  of the Company or
until their  successors have been duly elected and qualified.  The names of each
of the directors of the Company who were reelected at the Annual Meeting and the
votes cast "FOR" or for which authority to vote was "WITHHELD" is as follows:
<TABLE>
<CAPTION>

      Name                          For                     Withheld Authority

        <S>                         <C>                         <C>
         William G. Anderson        6,189,973                      39,871
         Alan C. Henderson          5,175,754                   1,054,090
         Richard E. Ragsdale        6,189,973                      39,871
         John H Short               6,189,973                      39,871
         H. Edwin Trusheim          6,188,727                      41,117
         Theodore M. Wight          6,188,727                      41,117
</TABLE>


Item 6 - Exhibits and Reports on Form 8-K

      (a) Exhibits

             27 Financial Data Schedule

      (b) Reports on Form 8-K

             None

                                    11 of 12


<PAGE> 12


                                         SIGNATURES




Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.



                                                    REHABCARE GROUP, INC.

May 10, 2000

                                                 By /s/     John R. Finkenkeller
                                                            John R. Finkenkeller
                                                       Senior Vice President and
                                                         Chief Financial Officer
                                                      (Chief Accounting Officer)


                                    12 of 12

<TABLE> <S> <C>


<ARTICLE>                     5

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                              DEC-31-2000
<PERIOD-END>                                   MAR-31-2000
<CASH>                                         963,000
<SECURITIES>                                   3,019,000
<RECEIVABLES>                                  83,617,000
<ALLOWANCES>                                   4,761,000
<INVENTORY>                                    0
<CURRENT-ASSETS>                               89,197,000
<PP&E>                                         8,211,000
<DEPRECIATION>                                 0
<TOTAL-ASSETS>                                 202,294,000
<CURRENT-LIABILITIES>                          49,849,000
<BONDS>                                        58,067,000
                          0
                                    0
<COMMON>                                       83,000
<OTHER-SE>                                     89,789,000
<TOTAL-LIABILITY-AND-EQUITY>                   202,294,000
<SALES>                                        105,933,000
<TOTAL-REVENUES>                               105,933,000
<CGS>                                          75,244,000
<TOTAL-COSTS>                                  95,346,000
<OTHER-EXPENSES>                               0
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             1,324,000
<INCOME-PRETAX>                                9,320,000
<INCOME-TAX>                                   3,709,000
<INCOME-CONTINUING>                            5,611,000
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   5,611,000
<EPS-BASIC>                                    .81
<EPS-DILUTED>                                  .73




</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission